HTS - Maximising the value of MRC Brain Banks

HTS - 最大化 MRC 脑库的价值

基本信息

  • 批准号:
    MC_PC_13044
  • 负责人:
  • 金额:
    $ 219.28万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Intramural
  • 财政年份:
    2013
  • 资助国家:
    英国
  • 起止时间:
    2013 至 无数据
  • 项目状态:
    已结题

项目摘要

The aim of this study to maximise the value of the brain tissue samples available to the research community in the four MRC-funded brain banks by the systematic analysis and integration of data from genomic studies on cases currently available for research in the banks. . All MRC brain banks have ethics approval to function as tissue banks and to collect, store and release tissue samples and data from consented donors. Consent/authorisation for genetic research is recorded and will be used to identify cases for inclusion in this study. Governance mechanisms include local NHS governance, Human Tissue Authority licences and Healthcare Improvement Scotland accreditation, along with MRC policies on research governance.This study will involve the investigation of normal brains from a wide age range and brains from well-characterised disease cohorts in the MRC brain banks. We aim to genetically characterise 1500 representative brains with Alzheimer disease, dementia with Lewy bodies /Parkinson disease, vascular dementia, frontotemporal dementia/motor neurone disease, Creutzfeldt-Jakob disease and controls. The data generated will greatly enrich the clinical and neuropathological data currently associated with these samples. This work will therefore provide major added value to the exiting brain banks, opening up totally new opportunities for mechanistic and translational research in neurodegeneration and brain aging.
本研究的目的是通过系统分析和整合目前可供脑库研究的病例的基因组研究数据,最大限度地发挥MRC资助的四个脑库中研究界可用的脑组织样本的价值。.所有MRC脑库都有伦理批准,可以作为组织库,收集、储存和发布来自同意捐赠者的组织样本和数据。记录遗传研究的知情同意/授权,并将用于确定纳入本研究的病例。治理机制包括当地NHS治理,人体组织管理局许可证和医疗保健改善苏格兰认证,沿着MRC政策的研究government.This研究将涉及调查的正常大脑从广泛的年龄范围和大脑的MRC脑库中的特征明确的疾病队列。我们的目标是从遗传学上研究1500例阿尔茨海默病、路易体痴呆/帕金森病、血管性痴呆、额颞叶痴呆/运动神经元疾病、克雅氏病和对照组的代表性大脑。生成的数据将极大地丰富目前与这些样本相关的临床和神经病理学数据。因此,这项工作将为现有的大脑银行提供重要的附加值,为神经变性和大脑老化的机制和转化研究开辟全新的机会。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains.
  • DOI:
    10.1136/jnnp-2017-317234
  • 发表时间:
    2018-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Keogh MJ;Wei W;Aryaman J;Wilson I;Talbot K;Turner MR;McKenzie CA;Troakes C;Attems J;Smith C;Al Sarraj S;Morris CM;Ansorge O;Pickering-Brown S;Jones N;Ironside JW;Chinnery PF
  • 通讯作者:
    Chinnery PF
Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.
  • DOI:
    10.1101/gr.210609.116
  • 发表时间:
    2017-01
  • 期刊:
  • 影响因子:
    7
  • 作者:
    Keogh MJ;Wei W;Wilson I;Coxhead J;Ryan S;Rollinson S;Griffin H;Kurzawa-Akanbi M;Santibanez-Koref M;Talbot K;Turner MR;McKenzie CA;Troakes C;Attems J;Smith C;Al Sarraj S;Morris CM;Ansorge O;Pickering-Brown S;Ironside JW;Chinnery PF
  • 通讯作者:
    Chinnery PF
Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains.
  • DOI:
    10.1186/s40478-016-0404-6
  • 发表时间:
    2017-02-02
  • 期刊:
  • 影响因子:
    7.1
  • 作者:
    Wei W;Keogh MJ;Wilson I;Coxhead J;Ryan S;Rollinson S;Griffin H;Kurzawa-Akanbi M;Santibanez-Koref M;Talbot K;Turner MR;McKenzie CA;Troakes C;Attems J;Smith C;Al Sarraj S;Morris CM;Ansorge O;Pickering-Brown S;Ironside JW;Chinnery PF
  • 通讯作者:
    Chinnery PF
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patrick Chinnery其他文献

Rare disease gene association discovery in the 100,000 Genomes Project
10 万基因组计划中的罕见病基因关联发现
  • DOI:
    10.1038/s41586-025-08623-w
  • 发表时间:
    2025-02-26
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Valentina Cipriani;Letizia Vestito;Emma F. Magavern;Julius O. B. Jacobsen;Gavin Arno;Elijah R. Behr;Katherine A. Benson;Marta Bertoli;Detlef Bockenhauer;Michael R. Bowl;Kate Burley;Li F. Chan;Patrick Chinnery;Peter J. Conlon;Marcos A. Costa;Alice E. Davidson;Sally J. Dawson;Elhussein A. E. Elhassan;Sarah E. Flanagan;Marta Futema;Daniel P. Gale;Sonia García-Ruiz;Cecilia Gonzalez Corcia;Helen R. Griffin;Sophie Hambleton;Amy R. Hicks;Henry Houlden;Richard S. Houlston;Sarah A. Howles;Robert Kleta;Iris Lekkerkerker;Siying Lin;Petra Liskova;Hannah H. Mitchison;Heba Morsy;Andrew D. Mumford;William G. Newman;Ruxandra Neatu;Edel A. O’Toole;Albert C. M. Ong;Alistair T. Pagnamenta;Shamima Rahman;Neil Rajan;Peter N. Robinson;Mina Ryten;Omid Sadeghi-Alavijeh;John A. Sayer;Claire L. Shovlin;Jenny C. Taylor;Omri Teltsh;Ian Tomlinson;Arianna Tucci;Clare Turnbull;Albertien M. van Eerde;James S. Ware;Laura M. Watts;Andrew R. Webster;Sarah K. Westbury;Sean L. Zheng;Mark Caulfield;Damian Smedley
  • 通讯作者:
    Damian Smedley
Correction to: A guide to writing systematic reviews of rare disease treatments to generate FAIRcompliant datasets: building a Treatabolome
更正:关于撰写罕见病治疗系统评价以生成符合 FAIR 原则的数据集的指南:构建治疗组学
  • DOI:
    10.1186/s13023-021-01777-6
  • 发表时间:
    2021-03-22
  • 期刊:
  • 影响因子:
    3.500
  • 作者:
    Antonio Atalaia;Rachel Thompson;Alberto Corvo;Leigh Carmody;Davide Piscia;Leslie Matalonga;Alfons Macaya;Angela Lochmuller;Bertrand Fontaine;Birte Zurek;Carles Hernandez-Ferrer;Carola Reinhard;David Gómez-Andrés;Jean-François Desaphy;Katherine Schon;Katja Lohmann;Matthew J. Jennings;Matthis Synofzik;Olaf Riess;Rabah Ben Yaou;Teresinha Evangelista;Thiloka Ratnaike;Virginie Bros-Facer;Gulcin Gumus;Rita Horvath;Patrick Chinnery;Steven Laurie;Holm Graessner;Peter Robinson;Hanns Lochmuller;Sergi Beltran;Gisèle Bonne
  • 通讯作者:
    Gisèle Bonne
Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction
住院后 1 年的 COVID-19 认知缺陷是全球性的,并且与脑损伤标志物升高和灰质体积减少有关
  • DOI:
    10.1038/s41591-024-03309-8
  • 发表时间:
    2024-09-23
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Greta K. Wood;Brendan F. Sargent;Zain-Ul-Abideen Ahmad;Kukatharmini Tharmaratnam;Cordelia Dunai;Franklyn N. Egbe;Naomi H. Martin;Bethany Facer;Sophie L. Pendered;Henry C. Rogers;Christopher Hübel;Daniel J. van Wamelen;Richard A. I. Bethlehem;Valentina Giunchiglia;Peter J. Hellyer;William Trender;Gursharan Kalsi;Edward Needham;Ava Easton;Thomas A. Jackson;Colm Cunningham;Rachel Upthegrove;Thomas A. Pollak;Matthew Hotopf;Tom Solomon;Sarah L. Pett;Pamela J. Shaw;Nicholas Wood;Neil A. Harrison;Karla L. Miller;Peter Jezzard;Guy Williams;Eugene P. Duff;Steven Williams;Fernando Zelaya;Stephen M. Smith;Simon Keller;Matthew Broome;Nathalie Kingston;Masud Husain;Angela Vincent;John Bradley;Patrick Chinnery;David K. Menon;John P. Aggleton;Timothy R. Nicholson;John-Paul Taylor;Anthony S. David;Alan Carson;Ed Bullmore;Gerome Breen;Adam Hampshire;Benedict D. Michael;Stella-Maria Paddick;E. Charles Leek
  • 通讯作者:
    E. Charles Leek

Patrick Chinnery的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patrick Chinnery', 18)}}的其他基金

Mitochondrial genomics in human health and diseases.(How variation in nuclear and mitochondrial DNA causes rare mitochondrial diseases and common late-onset human disorders)
人类健康和疾病中的线粒体基因组学。(核和线粒体 DNA 的变异如何导致罕见的线粒体疾病和常见的迟发性人类疾病)
  • 批准号:
    MC_UU_00028/7
  • 财政年份:
    2022
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Intramural
Mechanisms of oxygen toxicity in the context of mitochondrial dysfunction
线粒体功能障碍背景下的氧毒性机制
  • 批准号:
    MR/S035699/1
  • 财政年份:
    2019
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Research Grant
Newcastle University Single Cell Functional Genomics Unit (NUSCU)
纽卡斯尔大学单细胞功能基因组学单位 (NUSCU)
  • 批准号:
    MR/M008886/1
  • 财政年份:
    2015
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Research Grant
High-throughput Genomics and Transcriptomics of the Human Developmental Biology Resource
人类发育生物学资源的高通量基因组学和转录组学
  • 批准号:
    MC_PC_13047
  • 财政年份:
    2013
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Intramural

相似海外基金

Rural Co-Design and Collaboration: Maximising Rural Community Assets to Reduce Place-Based Health Inequalities
农村共同设计与协作:最大化农村社区资产以减少基于地点的健康不平等
  • 批准号:
    AH/Z505559/1
  • 财政年份:
    2024
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Research Grant
Uncovering the antimicrobial and antibiotic potentiating mechanism of acesulfame-K and maximising its topical therapeutic potential.
揭示安赛蜜的抗菌和抗生素增强机制并最大限度地发挥其局部治疗潜力。
  • 批准号:
    MR/Y001354/1
  • 财政年份:
    2024
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Research Grant
COEXIST-Maximising data from fragmented bone to understand the coexistence of late Neanderthals and early Homo sapiens in central and southeast Europe
共存——最大化来自碎片骨骼的数据,以了解中欧和东南欧晚期尼安德特人和早期智人的共存
  • 批准号:
    EP/Y037448/1
  • 财政年份:
    2024
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Research Grant
Maximising the value of the 2021 Northern Ireland Census
最大化 2021 年北爱尔兰人口普查的价值
  • 批准号:
    ES/Z502777/1
  • 财政年份:
    2024
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Research Grant
T-max: maximising insights from severe combined immunodeficiency and related disorders
T-max:最大限度地了解严重联合免疫缺陷和相关疾病
  • 批准号:
    MR/Y013395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Research Grant
A rEVOLUTIONary approach for maximising process water REuse and REsource REcovery through a smart, circular and integrated solution (R3volution)
通过智能、循环和集成解决方案 (R3volution) 实现工艺用水再利用和资源回收最大化的革命性方法
  • 批准号:
    10110156
  • 财政年份:
    2024
  • 资助金额:
    $ 219.28万
  • 项目类别:
    EU-Funded
Cheese from Peas: Maximising Use and Nutritional Value of UK Pulses for Dairy Alternatives.
豌豆奶酪:最大限度地提高英国豆类乳制品替代品的用途和营养价值。
  • 批准号:
    10072090
  • 财政年份:
    2023
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Collaborative R&D
Maximising tidal energy generation through Blade Scaling & Advanced Digital Engineering - MAXBlades
通过叶片缩放最大限度地提高潮汐能发电量
  • 批准号:
    10064409
  • 财政年份:
    2023
  • 资助金额:
    $ 219.28万
  • 项目类别:
    EU-Funded
The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk.
COVID-19 时代艾滋病毒的面貌不断变化:通过动态定位当前和未来的感染风险分布,最大限度地降低艾滋病毒发病率。
  • 批准号:
    10548290
  • 财政年份:
    2023
  • 资助金额:
    $ 219.28万
  • 项目类别:
Maximising urban green infrastructure for surface water flood management: an evidence-based approach
最大限度地利用城市绿色基础设施进行地表水洪水管理:基于证据的方法
  • 批准号:
    2890284
  • 财政年份:
    2023
  • 资助金额:
    $ 219.28万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了